Page 3 - Transcode Therapeutics News Today

TransCode Therapeutics shares increased by 16.7% to $0.42 during Monday's after-market session. Today's trading volume for this security ended up closing at…

BOSTON, Oct. 27, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more...

By Josh Beckerman Shares of TransCode Therapeutics rose 9.4% Tuesday after the company's chief executive and chief financial officer reported stock...

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 126,400 shares, an increase of 418.0% from the August 31st total of 24,400 shares. Approximately 7.1% of the company’s shares are sold short. Based on an […]

TransCode Therapeutics (NASDAQ:RNAZ) stock has seen a wild 24 hours of trading as the Boston headquartered nano-cap drug discovery firm rocketed Monday,...

TransCode Therapeutics (NASDAQ:RNAZ) shares took off after it announced positive results from a study of its lead drug candidate TTX-MC138 in mice models...

BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more...